Catalyst Wire Dossier Catalyst Wire Dossier

Agalsidase

agalsidase
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Agalsidase, covering 2018-11-01 to 2018-11-01. Get the full timeline:

Most recent: Clinical Trial Update: Drug-Drug Interaction Study Between AT1001 (Migalastat Hydrochloride) and Agalsidase in Participants With Fabry Disease [Phase 2]

See pricing